These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 15558213

  • 1. Regulation and interactions in the activation of cell-associated plasminogen.
    Myöhänen H, Vaheri A.
    Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH, Martin TJ.
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [Abstract] [Full Text] [Related]

  • 3. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
    Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Dano K, Carmeliet P, Collen D, Degen JL.
    Proc Natl Acad Sci U S A; 1996 Jun 11; 93(12):5899-904. PubMed ID: 8650190
    [Abstract] [Full Text] [Related]

  • 7. The fibrinolytic system: A new target for treatment of depression with psychedelics.
    Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S.
    Med Hypotheses; 2017 Mar 11; 100():46-53. PubMed ID: 28236848
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activation in human acute leukaemias.
    Scherrer A, Wohlwend A, Kruithof EK, Vassalli JD, Sappino AP.
    Br J Haematol; 1999 Jun 11; 105(4):920-7. PubMed ID: 10554801
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N, Maguire TM, Riisbro R, Geurts-Moespot A, O'Donovan N, Schmitt M, McGreal G, McDermott E, O'Higgins N, Brünner N, Sweep CG, Duffy MJ.
    Oncol Rep; 2005 Jul 11; 14(1):235-9. PubMed ID: 15944795
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The clinical prospects for the study of the plasminogen activation system in breast cancer].
    Gershteĭn ES, Kushlinskiĭ NE.
    Vestn Ross Akad Med Nauk; 1999 Jul 11; (8):58-61. PubMed ID: 10487126
    [Abstract] [Full Text] [Related]

  • 14. The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis.
    Herouy Y, Aizpurua J, Stetter C, Dichmann S, Idzko M, Hofmann C, Gitsch G, Vanscheidt W, Schöpf E, Norgauer J.
    J Cutan Pathol; 2001 Jul 11; 28(6):291-7. PubMed ID: 11401675
    [Abstract] [Full Text] [Related]

  • 15. Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development.
    Li M, Karakji EG, Xing R, Fryer JN, Carnegie JA, Rabbani SA, Tsang BK.
    Endocrinology; 1997 Jul 11; 138(7):2790-9. PubMed ID: 9202219
    [Abstract] [Full Text] [Related]

  • 16. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
    Boss EA, Massuger LF, Thomas CM, Geurts-Moespot A, van Schaik JH, Boonstra H, Sweep CG.
    Anticancer Res; 2002 Jul 11; 22(1A):275-82. PubMed ID: 12017303
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes.
    Liu YX, Hu ZY, Liu K, Byrne S, Zou RJ, Ny T, d'Lacey C, Ockleford CD.
    Placenta; 1998 Jul 11; 19(2-3):171-80. PubMed ID: 9548184
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.